Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Safety & Quality
January 27, 2022 10:23 PM

Two powerful drugs now adding to U.S. overdose crisis

Associated Press
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    cover pill container 4-22-19_i.jpg
    Getty Images/iStockphoto
    Empty prescription medicine bottle on natural white surface.

    Emerging reports show that two little-known drugs are making lethal new contributions to America's drug overdose crisis.

    Para-fluorofentanyl and metonitazene are being seen more often by medical examiners looking into overdose deaths, according to a government report published Thursday. They often are taken with — or mixed with — illicit fentanyl, the drug mainly responsible for the more than 100,000 U.S. overdose deaths in the last year.

    Increasingly, one or the other of the two drugs is the sole reason for some overdose deaths, said Dr. Darinka Mileusnic-Polchan, one of the report authors.

    Often injected or snorted, they are more powerful than fentanyl, she said.

    "These (victims) just crumple and collapse. Frequently they don't even inject the full syringe" before overdosing, said Mileusnic-Polchan, who leads the medical examiner's office in Knoxville, Tennessee.

    The overdose-reversing drug naloxone can still work, but more of it may be needed than when other drugs are involved, she said.

    Not a Modern Healthcare subscriber? Sign up today.

    Related Articles
    The powerful pairing of telemedicine and opioid addiction treatment
    Cities wracked by opioids close to getting $26B settlement

    The report, published by the Centers for Disease Control and Prevention for U.S. medical and public health professionals, is one of the first of its kind to raise alarms about the drugs. It was written by officials from the Drug Enforcement Administration; a toxicology lab at the University of California, San Francisco; and the Knox County Regional Forensic Center.

    The Knoxville area recorded 770 unintentional drug overdose deaths from November 2020 through August 2021, the authors wrote. Test results for 562 of them found fentanyl, and nearly 190 of those also tested positive for methamphetamine. But 48 involved para-fluorofentanyl, and 26 involved metonitazene, according to the report.

    And deaths involving those drugs have increased since the summer, Mileusnic-Polchan said.

    Para-fluorofentanyl is a synthetic opioid, like fentanyl. It was invented in the 1960s and has been sold illegally in the past, sometimes under the name "China-white."

    In 2020, investigators began seeing an uptick in overdoses involving the drug. Recently, it's been found in heroin packets and counterfeit pills.

    Metonitazene is from a class of painkillers developed in the 1950s but never authorized for medical treatment. That drug began appearing more often in overdose autopsy reports last year.

    It's not clear how widespread the drugs are. Cash-strapped medical examiner's offices and coroner's offices are not able to pay for toxicology work that looks for every conceivable drug, Mileusnic-Polchan said. Her office documented the two drugs because it participated in a DEA program that uses the UCSF lab for analysis.

    U.S. overdose deaths have been rising for more than two decades, but they accelerated in the past two years — jumping more than 20% in the latest year alone, according to the most recently available CDC data, through June 2021.

    Experts have said the top drivers are the growing prevalence of deadly fentanyl and the COVID-19 pandemic, which left many drug users socially isolated and unable to get treatment or other support.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    covid-USA-1_i.png
    U.S. deaths from COVID hit 1 million, less than 2 1/2 years in
    COVID U.S. map
    Death certificates reveal that U.S. hit grim COVID milestone
    Sponsored Content
    COVID-19 Coverage Newsletter: Sign up today to receive a comprehensive daily newsletter designed for healthcare leaders looking for the most accurate and comprehensive resources related to coronavirus.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing